YOLFTbeta
Oramed Pharmaceuticals Inc

Oramed Pharmaceuticals Inc

ORMP · NASDAQ · Healthcare / Biotechnology

3.71USD-0.32 (-7.94%)

Price History

Full chart

Market Stats

Previous Close4.03
Open4.03
Day Range3.67 – 4.12
52-Week Range1.95 – 5.47
Volume160.80K
Market Cap197.59M
P/E (TTM)1.15
Forward P/E0.00
EPS4.13
Dividend Yield5.29%
Beta1.19
50-Day Avg4.57
200-Day Avg3.88

About

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Nadav Kidron Esq.
  • Employees0
  • Headquarters1185 Avenue of the Americas, New York, NY, United States, 10036, USA
  • Websitehttps://oramed.com

Leadership

  • Mr. Nadav Kidron Esq.President, CEO & Executive Chairman · b. 1974
  • Mr. Joshua HexterChief Operating & Business Officer · b. 1970
  • Dr. Miriam Kidron Ph.D.Chief Scientific Officer & Director · b. 1940
  • Mr. Avraham GabayCFO, Treasurer & Secretary · b. 1985

Financials

Income Statement

Currency: USD2003-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-------197.41K184.25K---641.00K2.46M2.45M2.70M2.71M2.70M2.70M1.34M02.00M
Growth (%)---------6.67%----+283.15%-0.29%+10.37%+0.26%-0.26%0.00%-50.43%-100.00%-
Cost of Revenue------------490.00K187.00K86.00K90.00K90.00K---193.00K1.99M
Gross Profit-------197.41K184.25K---151.00K2.27M2.36M2.61M2.71M2.70M2.70M1.34M-193.00K13.00K
Gross Margin-------100.00%100.00%---23.56%92.39%96.49%96.67%100.00%100.00%100.00%100.00%-0.65%
Operating Expense-------2.63M-2.70M---10.16M13.04M15.89M17.24M14.47M26.93M43.30M17.11M12.59M15.10M
Operating Income-50.00K-44.81K-412.88K-3.13M-2.68M-2.78M-2.97M-2.44M2.88M-4.30M-5.91M-7.38M-10.01M-10.77M-13.53M-14.63M-11.76M-24.22M-40.60M-15.77M-12.78M-15.09M
Operating Margin--------1233.60%1565.24%----1561.62%-438.56%-552.35%-541.29%-433.84%-896.15%-1501.96%-1176.79%--754.40%
EBITDA-50.00K-720.00K-412.88K-3.02M-2.66M-2.72M-2.92M-2.37M-2.86M-4.13M-5.67M-7.38M-9.99M-10.76M-13.49M-14.17M-11.75M-24.15M-36.98M7.32M-14.87M75.44M
EBITDA Margin--------1202.43%-1550.11%----1558.35%-437.95%-550.88%-524.34%-433.58%-893.30%-1367.96%546.34%-3772.25%
Net Income-50.00K-45.78K-414.58K-3.24M-2.77M-2.76M-2.98M-1.56M-3.34M-4.23M-5.70M-7.23M-10.96M-10.48M-12.73M-14.36M-11.51M-22.24M-37.76M5.53M-19.06M64.05M
Net Income Margin--------790.86%-1815.15%----1710.45%-426.71%-519.68%-531.08%-424.76%-822.72%-1397.11%412.31%-3202.50%
R&D10.00K-197.75K2.21M1.18M1.52M1.46M1.16M1.68M2.27M3.28M4.78M7.71M10.28M11.98M13.52M10.23M20.99M27.64M8.97M6.32M6.38M
R&D as % of Total Revenue-------587.25%912.24%---1202.65%418.61%489.14%500.26%377.68%776.51%1022.53%669.48%-319.05%
Interest Expense-44.81K3.68K3.24M10.28K17.55K14.54K18.78K199.12K313.45K11.00K-11.00K6.00K6.00K126.00K-6.00K2.93M3.58M853.00K0
Interest Expense % of Total Revenue-------9.51%108.07%---1.72%0.24%0.24%4.66%-0.22%108.55%267.16%-0.00%

Balance Sheet

Currency: USD2003-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-1.26K176.19K1.94M5.51M3.26M1.45M4.33M5.29M8.66M21.80M26.35M42.83M38.71M47.40M34.66M44.63M128.00M161.64M220.55M155.28M230.86M
Total Liabilities10.00K46.07K608.91K1.42M913.95K515.66K620.62K602.02K1.52M529.41K1.01M1.53M16.64M19.47M16.29M15.27M11.75M11.48M10.49M57.66M9.93M31.12M
Total Equity-10.00K-44.81K-432.72K513.00K4.59M2.75M830.27K3.72M3.78M8.13M20.79M24.83M26.19M19.24M31.11M19.39M32.88M115.77M151.81M163.82M146.26M199.74M
Cash--40.44K176.19K1.92M2.27M1.72M1.20M1.51M4.43M2.27M1.76M3.21M3.91M3.97M5.00M3.33M19.30M77.25M40.46M9.05M54.42M45.95M
Total Debt---275.00K------------75.00K533.00K894.00K51.62M372.00K825.00K
Net Debt-40.44K-176.19K-1.64M-2.27M-1.72M-1.20M-1.51M-4.43M-2.27M-1.76M-3.21M-3.91M-3.97M-5.00M-3.33M-19.22M-76.71M-39.57M42.57M-54.05M-45.12M

Cash Flow

Currency: USD2003-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-40.00K-40.44K-361.61K-611.00K-1.84M-2.25M-1.42M-1.67M-2.30M-3.40M-4.07M-4.95M4.66M-5.83M-14.66M-12.94M-12.44M-21.18M-28.70M-10.29M-8.41M-9.14M
Investing Cash Flow----2.00K-2.84M1.72M901.24K-1.71M1.77M-4.57M-13.09M-3.31M-16.01M4.30M-7.00M11.26M4.63M-22.26M30.21M-73.04M105.82M5.44M
Financing Cash Flow-40.44K537.80K2.35M5.03M-152.93K3.69M3.49M5.82M16.64M9.72M12.04M1.59M22.65M-23.79M101.39M11.56M51.98M-52.04M-4.74M
Capital Expenditure0532.00K112.01K7.56K1.42M2.17K2.13K6.38K14.00K1.00K9.00K7.00K5.00K15.00K82.00K375.00K496.00K254.00K18.00K1.93M
Free Cash Flow-40.00K-40.44K-361.61K-613.00K-1.95M-2.26M-1.43M-1.67M-2.30M-3.40M-4.08M-4.95M4.65M-5.84M-14.66M-12.96M-12.52M-21.56M-29.20M-10.55M-8.43M-11.08M
Dividends Paid---------------------10.87M
FCF to OCF100.00%100.01%100.00%100.33%106.10%100.34%100.53%100.13%100.09%100.19%100.34%100.02%99.81%100.12%100.03%100.12%100.66%101.77%101.73%102.47%100.21%121.14%
Dividend Paid to FCF----------------------98.12%

Earnings

Report DateNov 30, 2005Feb 28, 2006May 31, 2006Aug 31, 2006Nov 30, 2006Feb 28, 2007May 31, 2007Aug 31, 2007Nov 30, 2007Feb 29, 2008May 31, 2008Aug 31, 2008Nov 30, 2008Feb 28, 2009May 31, 2009Aug 31, 2009Nov 30, 2009Feb 28, 2010May 31, 2010Aug 31, 2010Nov 30, 2010Feb 28, 2011May 31, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012May 31, 2012Aug 31, 2012Nov 30, 2012Feb 28, 2013Jul 31, 2013Oct 30, 2013Jan 14, 2014Apr 10, 2014Jul 14, 2014Nov 14, 2014Jan 8, 2015Apr 3, 2015Jul 1, 2015Nov 25, 2015Jan 13, 2016Apr 6, 2016Jul 6, 2016Nov 25, 2016Jan 11, 2017Apr 5, 2017Jul 6, 2017Nov 1, 2017Jan 11, 2018Apr 9, 2018Jul 12, 2018Nov 28, 2018Jan 14, 2019Apr 10, 2019Jul 10, 2019Nov 27, 2019Jan 8, 2020Apr 6, 2020Jul 7, 2020Nov 24, 2020Jan 14, 2021Apr 13, 2021Jul 14, 2021Nov 24, 2021Jan 11, 2022May 12, 2022Aug 10, 2022Nov 10, 2022Mar 6, 2023May 11, 2023Aug 10, 2023Nov 9, 2023Mar 6, 2024May 9, 2024Aug 14, 2024Nov 7, 2024Mar 4, 2025May 15, 2025Aug 14, 2025Nov 13, 2025Mar 26, 2026Jun 3, 2026Aug 10, 2026Nov 12, 2026
EPS Estimate---------------------------------0.16-0.18-0.15-0.20-0.21-0.22-0.18-0.18-0.18-0.19-0.19-0.18-0.12-0.19-0.27-0.23-0.21-0.29-0.27-0.29-0.19-0.26-0.24-0.24-0.23-0.17-0.20-0.21-0.19-0.17-0.24-0.18-0.16-0.27-0.24-0.26-0.23-0.25-0.09-0.09-0.120.02-0.02-0.020.02-0.03-0.04-0.04-0.08-0.430.43
EPS Actual-0.00-0.00-0.05-0.08-0.02-0.10-0.09-0.72-0.09-0.09-0.21-0.00-0.25-0.14-0.11-0.08-0.13-0.08-0.17-0.25-0.12-0.120.08-0.14-0.08-0.17-0.09-0.23-0.14-0.17-0.17-0.11-0.14-0.12-0.18-0.17-0.19-0.15-0.15-0.19-0.21-0.14-0.15-0.37-0.20-0.24-0.15-0.20-0.18-0.20-0.30-0.18-0.25-0.21-0.23-0.13-0.15-0.21-0.10-0.12-0.23-0.17-0.17-0.21-0.22-0.27-0.27-0.18-0.22-0.08-0.03-0.080.330.040.22-0.48-0.26-0.190.311.130.250.91-0.09-
Surprise--------------------------------12.50%33.33%-20.00%15.00%9.52%31.82%16.67%-5.56%-16.67%26.32%21.05%-105.56%-66.67%-26.32%44.44%13.04%14.29%31.03%-11.11%37.93%-31.58%19.23%4.17%45.83%34.78%-23.53%50.00%42.86%-21.05%0.00%29.17%-16.67%-37.50%0.00%-12.50%30.77%4.35%68.00%66.67%11.11%375.00%100.00%1200.00%-2300.00%-1376.00%-533.33%875.00%2925.00%412.50%--120.93%-
Timing--------------------------------After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-market-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hours

Key Statistics & Ratios

Market Cap197.59M
Enterprise Value146.46M
Trailing P/E1.15
Forward P/E0.00
PEG Ratio0.00
Price / Sales86.55
Price / Book0.62
EPS4.13
Book Value7.68
Revenue (TTM)0
Gross Profit (TTM)0
EBITDA-14.40M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity74.24%
Return on Assets-3.42%
Shares Outstanding41.60M
Shares Float29.85M
Beta1.19
Dividend Yield5.29%
Dividend Rate0.25
Payout Ratio11.35%

Analyst Ratings

Hold
Based on 1 analystsTarget 7.00
  • Hold
    1

Ownership Breakdown

Institutions
45.13%
Insiders
17.65%
Retail / Other
37.22%

Top Institutional Holders

  • Aquamarine Financial (Cayman) Ltd
    2.51M6.04%
  • Gem Investment Advisors, LLC
    2.00M4.81%
  • Mercer Global Advisors Inc.
    1.91M4.59%
  • Murchinson Ltd.
    1.32M3.16%
  • BML Capital Management LLC
    866.27K2.08%
  • BOOTHBAY FUND MANAGEMENT, LLC
    600.72K1.44%
  • Marshall Wace Asset Management Ltd
    259.61K0.62%
  • Rathbone Brothers PLC
    233.02K0.56%
  • Dimensional Fund Advisors, Inc.
    202.61K0.49%
  • Wells Fargo & Co
    157.59K0.38%
  • Renaissance Technologies Corp
    147.70K0.36%
  • Bank of America Corp
    146.15K0.35%
  • Susquehanna International Group, LLP
    136.22K0.33%
  • O'Shaughnessy Asset Management LLC
    116.36K0.28%
  • BlackRock Inc
    92.19K0.22%

Top Fund Holders

  • iShares Russell 2000 ETF
    625.04K1.50%
  • Fidelity Small Cap Index
    376.45K0.91%
  • iShares Russell 2000 Value ETF
    315.20K0.76%
  • Vanguard Russell 2000 ETF
    196.45K0.47%
  • iShares Micro-Cap ETF
    117.33K0.28%

Dividends

20261×
0.25Jan 16, 2026

Stock Splits

  • Jan 23, 20131:12